News

Capricor Therapeutics said on Friday the U.S. Food and Drug Administration has declined to approve its cell therapy ...
By Stephanie Brown HealthDay ReporterTHURSDAY, July 10, 2025 (HealthDay News) -- The U.S. Food and Drug Administration has ...
The FDA has accepted for priority review a new supplemental biologics license application for Winrevair to treat adults with ...
FDA approves Bravecto Quantum, the first injectable flea and tick treatment offering dogs up to 12 months of protection.
The U.S. Food and Drug Administration released more than 200 of its so-called complete response letters from its archive on ...
The federal government's investigation into a recall of Salmonella-contaminated brown cage-free and certified-organic eggs ...
A journey through the FDA’s newly released complete response letters gave glimpses into the journeys to market for Eli ...
Joe Lonsdale, co-founder of the large government contractor Palantir, wants to embed a team of 15 to 20 “elite engineers” ...
The FDA has released an “initial batch“ of more than 200 complete response letters (CRLs) in efforts to boost transparency. | ...
Food and Drug Administration Commissioner Marty Makary said his agency may fast-track new drugs from pharmaceutical companies that “equalize” the cost of their medicines between the US and other ...
The FDA has approved a long-acting drug to protect dogs against fleas and ticks. The drug, Bravecto Quantum, is given by ...
INDIANA- FDA advises consumers not to inhale nitrous oxide products from any size canisters, tanks, or chargers. These ...